Product NDC: | 66213-200 |
Proprietary Name: | Compazine |
Non Proprietary Name: | Prochlorperazine |
Active Ingredient(s): | 25 mg/1 & nbsp; Prochlorperazine |
Administration Route(s): | RECTAL |
Dosage Form(s): | SUPPOSITORY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66213-200 |
Labeler Name: | PBM Pharmaceuticals, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040246 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130701 |
Package NDC: | 66213-200-12 |
Package Description: | 25 SUPPOSITORY in 1 PACKET (66213-200-12) |
NDC Code | 66213-200-12 |
Proprietary Name | Compazine |
Package Description | 25 SUPPOSITORY in 1 PACKET (66213-200-12) |
Product NDC | 66213-200 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Prochlorperazine |
Dosage Form Name | SUPPOSITORY |
Route Name | RECTAL |
Start Marketing Date | 20130701 |
Marketing Category Name | ANDA |
Labeler Name | PBM Pharmaceuticals, Inc |
Substance Name | PROCHLORPERAZINE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |